Inflammatory Bowel Disease in Pediatric and Adolescent Patients: a Biomolecular and Histopathological Review

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2014 Aug 19

PMID 25132743

Citations 14

Authors

Luciana Rigoli

Rosario Alberto Caruso

Affiliations

Soon will be listed here.

Abstract

Crohn's disease (CD) and ulcerative colitis (UC) are the two main forms of inflammatory bowel disease (IBD) with both overlapping and distinct clinical, pathological and biomolecular features. It has been suggested that pediatric IBD is a distinct disease entity, with probably different disease subtypes.The aim of this study is to review and summarize the evolution of the current concept of pediatric IBD. The results of this review reinforce the idea that pediatric CD and UC may be further classified in various clinicopathologic entities. For clinicians and pathologists convenience, practical algorithms for the distinction of the various subphenotypes of pediatric IBD are also provided.

Citing Articles

Expression profiles of the lncRNA antisense GAS5-AS1 in colon biopsies from pediatric inflammatory bowel disease patients and its role in regulating sense transcript GAS5.

Curci D, Franzin M, Zudeh G, Bramuzzo M, Lega S, Decorti G Eur J Pediatr. 2024; 183(4):1657-1665.

PMID: 38197962 PMC: 11001710. DOI: 10.1007/s00431-023-05403-4.

PARP2 downregulation in T cells ameliorates lipopolysaccharide-induced inflammation of the large intestine.

Bencsics M, Banyai B, Ke H, Csepanyi-Komi R, Sasvari P, Dantzer F Front Immunol. 2023; 14:1135410.

PMID: 37457706 PMC: 10347374. DOI: 10.3389/fimmu.2023.1135410.

Endoplasmic Reticulum Stress in Colonic Mucosa of Ulcerative Colitis Patients Is Mediated by PERK and IRE1 Pathway Activation.

Rodrigues B, Dotti I, Pascoal L, Morari J, Esteller M, Coope A Mediators Inflamm. 2022; 2022:6049500.

PMID: 35185383 PMC: 8849912. DOI: 10.1155/2022/6049500.

Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease.

Giannoudaki E, Gargan S, Hussey S, Long A, Walsh P Front Pediatr. 2021; 9:640497.

PMID: 33816403 PMC: 8012547. DOI: 10.3389/fped.2021.640497.

Loss of Nckx3 Exacerbates Experimental DSS-Induced Colitis in Mice through p53/NF-κB Pathway.

Tran D, Go S, Park S, Jung E, Jeung E Int J Mol Sci. 2021; 22(5).

PMID: 33807999 PMC: 7961925. DOI: 10.3390/ijms22052645.

References

Franke A, Balschun T, Karlsen T, Sventoraityte J, Nikolaus S, Mayr G . Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet. 2008; 40(11):1319-23. DOI: 10.1038/ng.221. View

Garrison W, Battle M, Yang C, Kaestner K, Sladek F, Duncan S . Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. Gastroenterology. 2006; 130(4):1207-20. PMC: 3581272. DOI: 10.1053/j.gastro.2006.01.003. View

Saitoh T, Fujita N, Jang M, Uematsu S, Yang B, Satoh T . Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008; 456(7219):264-8. DOI: 10.1038/nature07383. View

Ferraris A, Knafelz D, Torres B, Fortina P, Castro M, Dallapiccola B . Analysis of CARD15 gene variants in Italian pediatric patients with inflammatory bowel diseases. J Pediatr. 2005; 147(2):272-3. DOI: 10.1016/j.jpeds.2005.03.039. View

Frye M, Bargon J, Lembcke B, Wagner T, Gropp R . Differential expression of human alpha- and beta-defensins mRNA in gastrointestinal epithelia. Eur J Clin Invest. 2000; 30(8):695-701. DOI: 10.1046/j.1365-2362.2000.00696.x. View

Zilbauer M, Jenke A, Wenzel G, Goedde D, Postberg J, Phillips A . Intestinal alpha-defensin expression in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2011; 17(10):2076-86. DOI: 10.1002/ibd.21577. View

Ishihara S, Aziz M, Yuki T, Kazumori H, Kinoshita Y . Inflammatory bowel disease: review from the aspect of genetics. J Gastroenterol. 2009; 44(11):1097-108. DOI: 10.1007/s00535-009-0141-8. View

Fellermann K, Stange D, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins C . A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet. 2006; 79(3):439-48. PMC: 1559531. DOI: 10.1086/505915. View

Stappenbeck T . Paneth cell development, differentiation, and function: new molecular cues. Gastroenterology. 2009; 137(1):30-3. DOI: 10.1053/j.gastro.2009.05.013. View

10.

Kugathasan S, Collins N, Maresso K, Hoffmann R, Stephens M, Werlin S . CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease. Clin Gastroenterol Hepatol. 2004; 2(11):1003-9. DOI: 10.1016/s1542-3565(04)00452-5. View

11.

Houlston R, Webb E, Broderick P, Pittman A, Di Bernardo M, Lubbe S . Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet. 2008; 40(12):1426-35. PMC: 2836775. DOI: 10.1038/ng.262. View

12.

Sagiv-Friedgut K, Karban A, Weiss B, Shaoul R, Shamir R, Bujanover Y . Early-onset Crohn disease is associated with male sex and a polymorphism in the IL-6 promoter. J Pediatr Gastroenterol Nutr. 2009; 50(1):22-6. DOI: 10.1097/MPG.0b013e3181b7a6a4. View

13.

Brant S . Update on the heritability of inflammatory bowel disease: the importance of twin studies. Inflamm Bowel Dis. 2010; 17(1):1-5. DOI: 10.1002/ibd.21385. View

14.

Cheng J, Ning Y, Zhang W, Lu Z, Lin L . T300A polymorphism of ATG16L1 and susceptibility to inflammatory bowel diseases: a meta-analysis. World J Gastroenterol. 2010; 16(10):1258-66. PMC: 2839180. DOI: 10.3748/wjg.v16.i10.1258. View

15.

Wine E, Reif S, Leshinsky-Silver E, Weiss B, Shaoul R, Shamir R . Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity. Pediatrics. 2004; 114(5):1281-6. DOI: 10.1542/peds.2004-0417. View

16.

Wehkamp J, Stange E . Paneth's disease. J Crohns Colitis. 2010; 4(5):523-31. DOI: 10.1016/j.crohns.2010.05.010. View

17.

Van Limbergen J, Russell R, Drummond H, Aldhous M, Round N, Nimmo E . Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008; 135(4):1114-22. DOI: 10.1053/j.gastro.2008.06.081. View

18.

Beil W, Weller P, Peppercorn M, Galli S, Dvorak A . Ultrastructural immunogold localization of subcellular sites of TNF-alpha in colonic Crohn's disease. J Leukoc Biol. 1995; 58(3):284-98. DOI: 10.1002/jlb.58.3.284. View

19.

Strugala V, Dettmar P, Pearson J . Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease. Int J Clin Pract. 2008; 62(5):762-9. DOI: 10.1111/j.1742-1241.2007.01665.x. View

20.

Feakins R . Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol. 2013; 66(12):1005-26. DOI: 10.1136/jclinpath-2013-201885. View